Skip to main content Accessibility help
×
Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-27T11:20:32.487Z Has data issue: false hasContentIssue false

Debate 20A - Should Patients with Platinum-sensitive Recurrent Ovarian Cancer Undergo Secondary Cytoreduction prior to Receiving Platinum-containing Second-line Chemotherapy?

Yes

from Section III - Ovarian Cancer

Published online by Cambridge University Press:  20 July 2023

Dennis S. Chi
Affiliation:
Memorial Sloan-Kettering Cancer Center, New York
Nisha Lakhi
Affiliation:
Richmond University Medical Center, Staten Island
Nicoletta Colombo
Affiliation:
University of Milan-Bicocca
Get access

Summary

The treatment of recurrent ovarian cancer and the role of secondary cytoreductive surgery has been discussed for many years. Three phase III trials focused on that aspect with different results, including patients with the first relapse and a platinum-free interval of at least six months. The GOG 213 trial failed to show an OS benefit for patients with secondary cytoreduction. The interim analysis of the SOC1 trial showed a PFS benefit of 5.5 months (17.4 versus 11.9) favoring surgery, OS data are not mature yet. The DESKTOP III trial revealed an extraordinary OS benefit of 14.5 months for patients with complete resection compared to patients without surgery (60.7 vs. 46.2 months). Therefore, secondary cytoreductive surgery should be offered to suitable patients. The selection of the right patient (e.g. by AGO score) and the right center is the most important step to take to achieve the best results for our patients.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Harter, P, et al. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial. Ann Surg Oncol 2006;13:17021710. https://doi.org/10.1245/s10434-006-9058-0CrossRefGoogle ScholarPubMed
Harter, P, et al. Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A Project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO. Int J Gynecol Cancer 2011;21:289295. https://doi.org/10.1097/IGC.0b013e31820aaafdCrossRefGoogle Scholar
Zang, R, et al. A randomized phase III trial of secondary cytoreductive surgery in later recurrent ovarian cancer: SOC1/SGOG-OV2. J Clin Oncol 2020;38:6001–6001. https://doi.org/10.1200/JCO.2020.38.15_suppl.6001CrossRefGoogle Scholar
Coleman, RL, et al. Secondary surgical cytoreduction for recurrent ovarian cancer. N Engl J Med 2019;381:19291939. https://doi.org/10.1056/NEJMoa1902626CrossRefGoogle ScholarPubMed
Du Bois, A, et al. Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer: final analysis of AGO DESKTOP III/ENGOT-ov20. J Clin Oncol 2020;38:6000. https://doi.org/10.1200/JCO.2020.38.15_suppl.6000CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×